Search tips
Search criteria 


Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. 2000 June; 82(11): 1887–1891.
PMCID: PMC2363233

Mortality from cutaneous melanoma: evidence for contrasting trends between populations


In recent years several reports have been published concerning trends in melanoma mortality in different countries, some of which have indicated that rates are beginning to fall. Many of these reports, however, have been based on small populations and have used different forms of statistical analysis. Our objective was to analyse systematically to what degree the epidemic of melanoma mortality had evolved similarly in different populations and whether there were any divergent trends that might increase our understanding. Instead of using all available data, we focused on countries with a minimum time series of 30 years and a minimum of 100 deaths annually in at least one sex from melanoma. We first inspected sex-specific age-standardized mortality rates and then performed age-period-cohort modelling. We found that the increase in mortality observed after 1950 was more pronounced in the age group 60–79. Statistical modelling showed a general increase in mortality rates in generations born after the turn of the century. Downturns in mortality, essentially in women and starting with generations born just before World War II, were found in Australia (where the earliest decreases were noted), the Nordic countries and the USA. Small decreases in rates in more recent generations were found in the UK and Canada. However, in France, Italy and Czechoslovakia, mortality rates were seen to be still increasing in recent cohorts. Our analysis suggests that populations are at different places on the melanoma mortality epidemic curve. The three trend patterns we observed are in agreement with time differences between populations with respect to the promotion of sun protection and the surveillance of pigmented skin lesions. © 2000 Cancer Research Campaign

Keywords: melanoma, mortality, trends, prevention programmes, sun exposure

Full Text

The Full Text of this article is available as a PDF (70K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surv. 1994;19-20:219–240. [PubMed]
  • Autier P, Doré JF. Influence of sun exposures during childhood and during adulthood on melanoma risk. EPIMEL and EORTC Melanoma Cooperative Group. European Organisation for Research and Treatment of Cancer. Int J Cancer. 1998 Aug 12;77(4):533–537. [PubMed]
  • Balzi D, Carli P, Geddes M. Malignant melanoma in Europe: changes in mortality rates (1970-90) in European Community countries. Cancer Causes Control. 1997 Jan;8(1):85–92. [PubMed]
  • Bleyen L, De Bacquer D, Myny K, Brochez L, Naeyaert JM, De Backer G. Trends in mortality from cutaneous malignant melanoma in Belgium. Int J Epidemiol. 1999 Feb;28(1):40–45. [PubMed]
  • Bucchi L, Serafini M, Lanzanova G. Breslow thickness of cutaneous malignant melanoma in Ravenna (northern Italy) 1981-1990. Tumori. 1992 Apr 30;78(2):94–97. [PubMed]
  • Burton RC, Armstrong BK. Recent incidence trends imply a nonmetastasizing form of invasive melanoma. Melanoma Res. 1994 Apr;4(2):107–113. [PubMed]
  • English DR, Milne E. Favorable trends in melanoma incidence: can we claim credit? Cancer Causes Control. 1999 Oct;10(5):403–405. [PubMed]
  • Giles GG, Armstrong BK, Burton RC, Staples MP, Thursfield VJ. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. BMJ. 1996 May 4;312(7039):1121–1125. [PMC free article] [PubMed]
  • Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics. 1983 Jun;39(2):311–324. [PubMed]
  • Holford TR. Analysing the temporal effects of age, period and cohort. Stat Methods Med Res. 1992;1(3):317–337. [PubMed]
  • La Vecchia C, Lucchini F, Negri E, Levi F. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer. 1999 Mar 31;81(1):62–66. [PubMed]
  • Lee JA, Petersen GR, Stevens RG, Vesanen K. The influence of age, year of birth, and date on mortality from malignant melanoma in the populations of England and Wales, Canada, and the white population of the United States. Am J Epidemiol. 1979 Dec;110(6):734–739. [PubMed]
  • MacKie RM, Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. BMJ. 1992 Apr 18;304(6833):1012–1015. [PMC free article] [PubMed]
  • MacKie R, Hunter JA, Aitchison TC, Hole D, Mclaren K, Rankin R, Blessing K, Evans AT, Hutcheon AW, Jones DH, et al. Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet. 1992 Apr 18;339(8799):971–975. [PubMed]
  • MacKie RM, Hole D, Hunter JA, Rankin R, Evans A, McLaren K, Fallowfield M, Hutcheon A, Morris A. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group. BMJ. 1997 Nov 1;315(7116):1117–1121. [PMC free article] [PubMed]
  • Måsbäck A, Westerdahl J, Ingvar C, Olsson H, Jonsson N. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review. Cancer. 1994 Mar 15;73(6):1625–1630. [PubMed]
  • Melia J. Early detection of cutaneous malignant melanoma in Britain. Int J Epidemiol. 1995;24 (Suppl 1):S39–S44. [PubMed]
  • Rivers JK, Gallagher RP. Public education projects in skin cancer. Experience of the Canadian Dermatology Association. Cancer. 1995 Jan 15;75(2 Suppl):661–666. [PubMed]
  • Robinson JK, Rigel DS, Amonette RA. Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996. J Am Acad Dermatol. 1997 Aug;37(2 Pt 1):179–186. [PubMed]
  • Roush GC, McKay L, Holford TR. A reversal in the long-term increase in deaths attributable to malignant melanoma. Cancer. 1992 Apr 1;69(7):1714–1720. [PubMed]
  • Scotto J, Pitcher H, Lee JA. Indications of future decreasing trends in skin-melanoma mortality among whites in the United States. Int J Cancer. 1991 Oct 21;49(4):490–497. [PubMed]
  • Swerdlow AJ. International trends in cutaneous melanoma. Ann N Y Acad Sci. 1990;609:235–251. [PubMed]
  • Thörn M, Pontén F, Bergström R, Sparén P, Adami HO. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst. 1994 May 18;86(10):761–769. [PubMed]
  • van der Spek-Keijser LM, van der Rhee HJ, Tóth G, Van Westering R, Bruijn JA, Coebergh JW. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980. Br J Dermatol. 1997 Apr;136(4):565–571. [PubMed]
  • Venzon DJ, Moolgavkar SH. Cohort analysis of malignant melanoma in five countries. Am J Epidemiol. 1984 Jan;119(1):62–70. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK